Kinetic parameters describing the inactivation of P450 2C9 by tienilic acid and (±)-suprofen when different probe substrates are used to measure residual activity
Data were fit to both a hyperbolic equation (eq. 1) and the Hill equation (eq. 2), as described under Materials and Methods. Efficiency of inactivation was calculated as the ratio of kinact to KI.
Inactivator | Substrate | kinact | KI | n | Efficiency |
---|---|---|---|---|---|
min-1 | μM | ml/min/μmol | |||
Tienilic acid | (S)-Flurbiprofena | 0.18 | 19.2 | 1.6 | 9.4 |
Diclofenaca | 0.17 | 20.1 | 2.1 | 8.5 | |
(S)-Warfarinb | 0.13 | 12.5 | 10.4 | ||
(±)-Suprofen | (S)-Flurbiprofena | 0.03 | 24.2 | 1.4 | 1.2 |
Diclofenaca | 0.03 | 26.6 | 1.3 | 1.1 | |
| (S)-Warfarinb | 0.02 | 6.7 |
| 3.0 |